2024 Archives - Page 3 of 3 - MaaT Pharma

Press Releases

March 7, 2024: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…

MaaT PharmaMarch 7, 2024

Press Releases

March 7, 2024: MaaT Pharma Releases its 2024 Financial Calendar

MaaT Pharma Releases its 2024 Financial Calendar Lyon, France, March 7, 2024 –6:00pm CET –…

MaaT PharmaMarch 7, 2024

Press Releases

March 5, 2024: MaaT Pharma indicates completion of Patient Recruitment for the Phase 2a Investigator-Sponsored Randomized Clinical Trial Evaluating MaaT013 in Combination with Immune Checkpoint Inhibitors in Metastatic Melanoma

MaaT Pharma indicates completion of Patient Recruitment for the Phase 2a Investigator-Sponsored Randomized Clinical Trial…

MaaT PharmaMarch 5, 2024

© 2024 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club